FDA Announces Submission of Information Collection for Review Under Paperwork Reduction Act

Summary

The Food and Drug Administration (FDA) has submitted a request for review and clearance from the Office of Management and Budget (OMB) regarding the proposed collection of information, as part of the Paperwork Reduction Act of 1995, related to a claim for Generally Recognized as Safe (GRAS) exemption.